BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 7315413)

  • 21. Vasoactive intestinal polypeptide (VIP) in the male genitourinary tract: concentration and motor effect.
    Larsen JJ; Ottesen B; Fahrenkrug J; Fahrenkrug L
    Invest Urol; 1981 Nov; 19(3):211-3. PubMed ID: 7298295
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vasoactive intestinal polypeptide (VIP) as a putative neurotransmitter in penile erection.
    Willis EA; Ottesen B; Wagner G; Sundler F; Fahrenkrug J
    Life Sci; 1983 Jul; 33(4):383-91. PubMed ID: 6410140
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of acetylcholine and vasoactive intestinal peptide on cerebral blood flow.
    Heistad DD; Marcus ML; Said SI; Gross PM
    Am J Physiol; 1980 Jul; 239(1):H73-80. PubMed ID: 7396021
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efffect of vasoactive intestinal polypeptide on gallbladder smooth muscle in vitro.
    Ryan JP; Ryave S
    Am J Physiol; 1978 Jan; 234(1):E44-6. PubMed ID: 623247
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Complementary role of vasoactive intestinal polypeptide (VIP) and acetylcholine for cat submandibular gland blood flow and secretion. II. Effects of cholinergic antagonists and VIP antiserum.
    Lundberg JM; Anggård A; Fahrenkrug J
    Acta Physiol Scand; 1981; 113(3):329-36. PubMed ID: 7345899
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of vasoactive intestinal polypeptide on uterine blood flow in pregnant ewes.
    Clark KE; Austin JE; Stys SJ
    Am J Obstet Gynecol; 1982 Nov; 144(5):497-502. PubMed ID: 7137236
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of vasoactive intestinal polypeptide on blood flow, motility and fluid transport in the gastrointestinal tract of the cat.
    Eklund S; Jodal M; Lundgren O; Sjöqvist A
    Acta Physiol Scand; 1979 Apr; 105(4):461-8. PubMed ID: 452923
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of vasoactive intestinal polypeptide (VIP) on rabbit cavernosal smooth muscle contractility.
    Kim YC; Choi HK; Ahn YS; Kim KH; Hagen PO; Carson CC
    J Androl; 1994; 15(5):392-7. PubMed ID: 7860419
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of vasoactive intestinal polypeptide (VIP) on the in vitro and in vivo motility of the rabbit reproductive tract.
    Fredericks CM; Ashton SH
    Fertil Steril; 1982 Jun; 37(6):845-50. PubMed ID: 7084506
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vasoactive intestinal polypeptide-sensitive cyclic adenosine monophosphate generating system in the rat portal vein.
    Amenta D; Iacopino L; Amenta F
    Arch Int Pharmacodyn Ther; 1988; 291():88-95. PubMed ID: 2835024
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vasoactive intestinal polypeptide is more potent than prostaglandin E2 as a vasodilator and oedema potentiator in rabbit skin.
    Williams TJ
    Br J Pharmacol; 1982 Nov; 77(3):505-9. PubMed ID: 6958342
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of vasoactive intestinal polypeptide on basal and cholecystokinin-induced gallbladder pressure.
    Ryan J; Cohen S
    Gastroenterology; 1977 Oct; 73(4 Pt 1):870-2. PubMed ID: 892388
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of Na(+)-K(+)-ATPase in airway smooth muscle relaxation by vasoactive intestinal peptide and pituitary adenylate cyclase activating peptide.
    Kanemura T; Tamaoki J; Chiyotani A; Takeyama K; Sakai N; Tagaya E; Konno K
    Res Commun Chem Pathol Pharmacol; 1993 Jan; 79(1):11-22. PubMed ID: 8381977
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of vasoactive intestinal polypeptide receptor mRNA and secretory regulation by vasoactive intestinal polypeptide in rat submandibular and sublingual salivary glands.
    Takai N; Yoshida Y; Shida T; Kondo E; Ueda Y; Kiyama H; Tohyama M
    Arch Oral Biol; 1997 Mar; 42(3):197-204. PubMed ID: 9188989
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vasoactive intestinal peptide and cholinergic neurotransmission in the ciliary muscle.
    Suzuki R; Kobayashi S
    Invest Ophthalmol Vis Sci; 1983 Feb; 24(2):250-3. PubMed ID: 6826329
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vasoactive intestinal polypeptide (VIP): effects in the eye and on regional blood flows.
    Nilsson SF; Bill A
    Acta Physiol Scand; 1984 Aug; 121(4):385-92. PubMed ID: 6148840
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ACh- and VIP-induced vasorelaxation in rabbit facial artery after carotid artery occlusion.
    Roganović J; Radenković M; Stojić D
    Arch Oral Biol; 2010 May; 55(5):333-42. PubMed ID: 20359690
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunohistochemical localization and vascular effects of vasoactive intestinal polypeptide in skeletal muscle of the cat.
    Järhult J; Hellstrand P; Sundler F
    Cell Tissue Res; 1980; 207(1):55-64. PubMed ID: 7388912
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Measurement of myometrial blood flow in rabbits by washout of xenon-133 after atraumatic local labelling.
    Ottesen B
    Acta Physiol Scand; 1980 Aug; 109(4):421-6. PubMed ID: 7468261
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The inhibitory effects of vasoactive intestinal polypeptide on the mechanical and electrical activity of canine antral smooth muscle.
    Morgan KG; Schmalz PF; Szurszewski JH
    J Physiol; 1978 Sep; 282():437-50. PubMed ID: 722548
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.